Global Specialty Biopharmaceutical Excipients Market Insights, Forecast to 2028

Report ID: 1752051 | Published Date: Jan 2025 | No. of Page: 109 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
1 Study Coverage
    1.1 Specialty Biopharmaceutical Excipients Product Introduction
    1.2 Market by Type
        1.2.1 Global Specialty Biopharmaceutical Excipients Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 膨胀剂
        1.2.3 溶解度增强剂
        1.2.4 表面活性剂
        1.2.5 其他
    1.3 Market by Application
        1.3.1 Global Specialty Biopharmaceutical Excipients Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Oral Medication
        1.3.3 Injection Medicine
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Specialty Biopharmaceutical Excipients Sales Estimates and Forecasts 2017-2028
    2.2 Global Specialty Biopharmaceutical Excipients Revenue Estimates and Forecasts 2017-2028
    2.3 Global Specialty Biopharmaceutical Excipients Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Specialty Biopharmaceutical Excipients Sales by Region
        2.4.1 Global Specialty Biopharmaceutical Excipients Sales by Region (2017-2022)
        2.4.2 Global Sales Specialty Biopharmaceutical Excipients by Region (2023-2028)
    2.5 Global Specialty Biopharmaceutical Excipients Revenue by Region
        2.5.1 Global Specialty Biopharmaceutical Excipients Revenue by Region (2017-2022)
        2.5.2 Global Specialty Biopharmaceutical Excipients Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Specialty Biopharmaceutical Excipients Sales by Manufacturers
        3.1.1 Global Top Specialty Biopharmaceutical Excipients Manufacturers by Sales (2017-2022)
        3.1.2 Global Specialty Biopharmaceutical Excipients Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Specialty Biopharmaceutical Excipients in 2021
    3.2 Global Specialty Biopharmaceutical Excipients Revenue by Manufacturers
        3.2.1 Global Specialty Biopharmaceutical Excipients Revenue by Manufacturers (2017-2022)
        3.2.2 Global Specialty Biopharmaceutical Excipients Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Specialty Biopharmaceutical Excipients Revenue in 2021
    3.3 Global Specialty Biopharmaceutical Excipients Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Specialty Biopharmaceutical Excipients Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Specialty Biopharmaceutical Excipients Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Specialty Biopharmaceutical Excipients Sales by Type
        4.1.1 Global Specialty Biopharmaceutical Excipients Historical Sales by Type (2017-2022)
        4.1.2 Global Specialty Biopharmaceutical Excipients Forecasted Sales by Type (2023-2028)
        4.1.3 Global Specialty Biopharmaceutical Excipients Sales Market Share by Type (2017-2028)
    4.2 Global Specialty Biopharmaceutical Excipients Revenue by Type
        4.2.1 Global Specialty Biopharmaceutical Excipients Historical Revenue by Type (2017-2022)
        4.2.2 Global Specialty Biopharmaceutical Excipients Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Specialty Biopharmaceutical Excipients Revenue Market Share by Type (2017-2028)
    4.3 Global Specialty Biopharmaceutical Excipients Price by Type
        4.3.1 Global Specialty Biopharmaceutical Excipients Price by Type (2017-2022)
        4.3.2 Global Specialty Biopharmaceutical Excipients Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Specialty Biopharmaceutical Excipients Sales by Application
        5.1.1 Global Specialty Biopharmaceutical Excipients Historical Sales by Application (2017-2022)
        5.1.2 Global Specialty Biopharmaceutical Excipients Forecasted Sales by Application (2023-2028)
        5.1.3 Global Specialty Biopharmaceutical Excipients Sales Market Share by Application (2017-2028)
    5.2 Global Specialty Biopharmaceutical Excipients Revenue by Application
        5.2.1 Global Specialty Biopharmaceutical Excipients Historical Revenue by Application (2017-2022)
        5.2.2 Global Specialty Biopharmaceutical Excipients Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Specialty Biopharmaceutical Excipients Revenue Market Share by Application (2017-2028)
    5.3 Global Specialty Biopharmaceutical Excipients Price by Application
        5.3.1 Global Specialty Biopharmaceutical Excipients Price by Application (2017-2022)
        5.3.2 Global Specialty Biopharmaceutical Excipients Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Specialty Biopharmaceutical Excipients Market Size by Type
        6.1.1 North America Specialty Biopharmaceutical Excipients Sales by Type (2017-2028)
        6.1.2 North America Specialty Biopharmaceutical Excipients Revenue by Type (2017-2028)
    6.2 North America Specialty Biopharmaceutical Excipients Market Size by Application
        6.2.1 North America Specialty Biopharmaceutical Excipients Sales by Application (2017-2028)
        6.2.2 North America Specialty Biopharmaceutical Excipients Revenue by Application (2017-2028)
    6.3 North America Specialty Biopharmaceutical Excipients Market Size by Country
        6.3.1 North America Specialty Biopharmaceutical Excipients Sales by Country (2017-2028)
        6.3.2 North America Specialty Biopharmaceutical Excipients Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Specialty Biopharmaceutical Excipients Market Size by Type
        7.1.1 Europe Specialty Biopharmaceutical Excipients Sales by Type (2017-2028)
        7.1.2 Europe Specialty Biopharmaceutical Excipients Revenue by Type (2017-2028)
    7.2 Europe Specialty Biopharmaceutical Excipients Market Size by Application
        7.2.1 Europe Specialty Biopharmaceutical Excipients Sales by Application (2017-2028)
        7.2.2 Europe Specialty Biopharmaceutical Excipients Revenue by Application (2017-2028)
    7.3 Europe Specialty Biopharmaceutical Excipients Market Size by Country
        7.3.1 Europe Specialty Biopharmaceutical Excipients Sales by Country (2017-2028)
        7.3.2 Europe Specialty Biopharmaceutical Excipients Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Specialty Biopharmaceutical Excipients Market Size by Type
        8.1.1 Asia Pacific Specialty Biopharmaceutical Excipients Sales by Type (2017-2028)
        8.1.2 Asia Pacific Specialty Biopharmaceutical Excipients Revenue by Type (2017-2028)
    8.2 Asia Pacific Specialty Biopharmaceutical Excipients Market Size by Application
        8.2.1 Asia Pacific Specialty Biopharmaceutical Excipients Sales by Application (2017-2028)
        8.2.2 Asia Pacific Specialty Biopharmaceutical Excipients Revenue by Application (2017-2028)
    8.3 Asia Pacific Specialty Biopharmaceutical Excipients Market Size by Region
        8.3.1 Asia Pacific Specialty Biopharmaceutical Excipients Sales by Region (2017-2028)
        8.3.2 Asia Pacific Specialty Biopharmaceutical Excipients Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Specialty Biopharmaceutical Excipients Market Size by Type
        9.1.1 Latin America Specialty Biopharmaceutical Excipients Sales by Type (2017-2028)
        9.1.2 Latin America Specialty Biopharmaceutical Excipients Revenue by Type (2017-2028)
    9.2 Latin America Specialty Biopharmaceutical Excipients Market Size by Application
        9.2.1 Latin America Specialty Biopharmaceutical Excipients Sales by Application (2017-2028)
        9.2.2 Latin America Specialty Biopharmaceutical Excipients Revenue by Application (2017-2028)
    9.3 Latin America Specialty Biopharmaceutical Excipients Market Size by Country
        9.3.1 Latin America Specialty Biopharmaceutical Excipients Sales by Country (2017-2028)
        9.3.2 Latin America Specialty Biopharmaceutical Excipients Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Specialty Biopharmaceutical Excipients Market Size by Type
        10.1.1 Middle East and Africa Specialty Biopharmaceutical Excipients Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Specialty Biopharmaceutical Excipients Revenue by Type (2017-2028)
    10.2 Middle East and Africa Specialty Biopharmaceutical Excipients Market Size by Application
        10.2.1 Middle East and Africa Specialty Biopharmaceutical Excipients Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Specialty Biopharmaceutical Excipients Revenue by Application (2017-2028)
    10.3 Middle East and Africa Specialty Biopharmaceutical Excipients Market Size by Country
        10.3.1 Middle East and Africa Specialty Biopharmaceutical Excipients Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Specialty Biopharmaceutical Excipients Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Merck KGaA
        11.1.1 Merck KGaA Corporation Information
        11.1.2 Merck KGaA Overview
        11.1.3 Merck KGaA Specialty Biopharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Merck KGaA Specialty Biopharmaceutical Excipients Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Merck KGaA Recent Developments
    11.2 Signet Excipients Pvt. Ltd
        11.2.1 Signet Excipients Pvt. Ltd Corporation Information
        11.2.2 Signet Excipients Pvt. Ltd Overview
        11.2.3 Signet Excipients Pvt. Ltd Specialty Biopharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Signet Excipients Pvt. Ltd Specialty Biopharmaceutical Excipients Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Signet Excipients Pvt. Ltd Recent Developments
    11.3 Sigachi Industries Limited
        11.3.1 Sigachi Industries Limited Corporation Information
        11.3.2 Sigachi Industries Limited Overview
        11.3.3 Sigachi Industries Limited Specialty Biopharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Sigachi Industries Limited Specialty Biopharmaceutical Excipients Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Sigachi Industries Limited Recent Developments
    11.4 Associated British Foods plc
        11.4.1 Associated British Foods plc Corporation Information
        11.4.2 Associated British Foods plc Overview
        11.4.3 Associated British Foods plc Specialty Biopharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Associated British Foods plc Specialty Biopharmaceutical Excipients Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Associated British Foods plc Recent Developments
    11.5 Spectrum Chemical Manufacturing Corp.
        11.5.1 Spectrum Chemical Manufacturing Corp. Corporation Information
        11.5.2 Spectrum Chemical Manufacturing Corp. Overview
        11.5.3 Spectrum Chemical Manufacturing Corp. Specialty Biopharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Spectrum Chemical Manufacturing Corp. Specialty Biopharmaceutical Excipients Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Spectrum Chemical Manufacturing Corp. Recent Developments
    11.6 Roquette Freres
        11.6.1 Roquette Freres Corporation Information
        11.6.2 Roquette Freres Overview
        11.6.3 Roquette Freres Specialty Biopharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Roquette Freres Specialty Biopharmaceutical Excipients Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Roquette Freres Recent Developments
    11.7 IMCD
        11.7.1 IMCD Corporation Information
        11.7.2 IMCD Overview
        11.7.3 IMCD Specialty Biopharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 IMCD Specialty Biopharmaceutical Excipients Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 IMCD Recent Developments
    11.8 Clariant
        11.8.1 Clariant Corporation Information
        11.8.2 Clariant Overview
        11.8.3 Clariant Specialty Biopharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Clariant Specialty Biopharmaceutical Excipients Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Clariant Recent Developments
    11.9 DFE Pharma
        11.9.1 DFE Pharma Corporation Information
        11.9.2 DFE Pharma Overview
        11.9.3 DFE Pharma Specialty Biopharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 DFE Pharma Specialty Biopharmaceutical Excipients Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 DFE Pharma Recent Developments
    11.10 Colorcon
        11.10.1 Colorcon Corporation Information
        11.10.2 Colorcon Overview
        11.10.3 Colorcon Specialty Biopharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Colorcon Specialty Biopharmaceutical Excipients Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Colorcon Recent Developments
    11.11 BASF
        11.11.1 BASF Corporation Information
        11.11.2 BASF Overview
        11.11.3 BASF Specialty Biopharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 BASF Specialty Biopharmaceutical Excipients Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 BASF Recent Developments
    11.12 Evonik Industries
        11.12.1 Evonik Industries Corporation Information
        11.12.2 Evonik Industries Overview
        11.12.3 Evonik Industries Specialty Biopharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Evonik Industries Specialty Biopharmaceutical Excipients Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Evonik Industries Recent Developments
    11.13 J. RETTENMAIER & SOHNE GmbH
        11.13.1 J. RETTENMAIER & SOHNE GmbH Corporation Information
        11.13.2 J. RETTENMAIER & SOHNE GmbH Overview
        11.13.3 J. RETTENMAIER & SOHNE GmbH Specialty Biopharmaceutical Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 J. RETTENMAIER & SOHNE GmbH Specialty Biopharmaceutical Excipients Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 J. RETTENMAIER & SOHNE GmbH Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Specialty Biopharmaceutical Excipients Industry Chain Analysis
    12.2 Specialty Biopharmaceutical Excipients Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Specialty Biopharmaceutical Excipients Production Mode & Process
    12.4 Specialty Biopharmaceutical Excipients Sales and Marketing
        12.4.1 Specialty Biopharmaceutical Excipients Sales Channels
        12.4.2 Specialty Biopharmaceutical Excipients Distributors
    12.5 Specialty Biopharmaceutical Excipients Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Specialty Biopharmaceutical Excipients Industry Trends
    13.2 Specialty Biopharmaceutical Excipients Market Drivers
    13.3 Specialty Biopharmaceutical Excipients Market Challenges
    13.4 Specialty Biopharmaceutical Excipients Market Restraints
14 Key Findings in The Global Specialty Biopharmaceutical Excipients Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Specialty Biopharmaceutical Excipients Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of 膨胀剂
    Table 3. Major Manufacturers of 溶解度增强剂
    Table 4. Major Manufacturers of 表面活性剂
    Table 5. Major Manufacturers of 其他
    Table 6. Global Specialty Biopharmaceutical Excipients Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Specialty Biopharmaceutical Excipients Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Specialty Biopharmaceutical Excipients Sales by Region (2017-2022) & (Tons)
    Table 9. Global Specialty Biopharmaceutical Excipients Sales Market Share by Region (2017-2022)
    Table 10. Global Specialty Biopharmaceutical Excipients Sales by Region (2023-2028) & (Tons)
    Table 11. Global Specialty Biopharmaceutical Excipients Sales Market Share by Region (2023-2028)
    Table 12. Global Specialty Biopharmaceutical Excipients Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Specialty Biopharmaceutical Excipients Revenue Market Share by Region (2017-2022)
    Table 14. Global Specialty Biopharmaceutical Excipients Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Specialty Biopharmaceutical Excipients Revenue Market Share by Region (2023-2028)
    Table 16. Global Specialty Biopharmaceutical Excipients Sales by Manufacturers (2017-2022) & (Tons)
    Table 17. Global Specialty Biopharmaceutical Excipients Sales Share by Manufacturers (2017-2022)
    Table 18. Global Specialty Biopharmaceutical Excipients Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Specialty Biopharmaceutical Excipients Revenue Share by Manufacturers (2017-2022)
    Table 20. Specialty Biopharmaceutical Excipients Price by Manufacturers (2017-2022) &(US$/Ton)
    Table 21. Global Specialty Biopharmaceutical Excipients Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Specialty Biopharmaceutical Excipients by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Specialty Biopharmaceutical Excipients as of 2021)
    Table 23. Specialty Biopharmaceutical Excipients Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Specialty Biopharmaceutical Excipients Product Offered
    Table 25. Date of Manufacturers Enter into Specialty Biopharmaceutical Excipients Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Specialty Biopharmaceutical Excipients Sales by Type (2017-2022) & (Tons)
    Table 28. Global Specialty Biopharmaceutical Excipients Sales by Type (2023-2028) & (Tons)
    Table 29. Global Specialty Biopharmaceutical Excipients Sales Share by Type (2017-2022)
    Table 30. Global Specialty Biopharmaceutical Excipients Sales Share by Type (2023-2028)
    Table 31. Global Specialty Biopharmaceutical Excipients Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Specialty Biopharmaceutical Excipients Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Specialty Biopharmaceutical Excipients Revenue Share by Type (2017-2022)
    Table 34. Global Specialty Biopharmaceutical Excipients Revenue Share by Type (2023-2028)
    Table 35. Specialty Biopharmaceutical Excipients Price by Type (2017-2022) & (US$/Ton)
    Table 36. Global Specialty Biopharmaceutical Excipients Price Forecast by Type (2023-2028) & (US$/Ton)
    Table 37. Global Specialty Biopharmaceutical Excipients Sales by Application (2017-2022) & (Tons)
    Table 38. Global Specialty Biopharmaceutical Excipients Sales by Application (2023-2028) & (Tons)
    Table 39. Global Specialty Biopharmaceutical Excipients Sales Share by Application (2017-2022)
    Table 40. Global Specialty Biopharmaceutical Excipients Sales Share by Application (2023-2028)
    Table 41. Global Specialty Biopharmaceutical Excipients Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Specialty Biopharmaceutical Excipients Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Specialty Biopharmaceutical Excipients Revenue Share by Application (2017-2022)
    Table 44. Global Specialty Biopharmaceutical Excipients Revenue Share by Application (2023-2028)
    Table 45. Specialty Biopharmaceutical Excipients Price by Application (2017-2022) & (US$/Ton)
    Table 46. Global Specialty Biopharmaceutical Excipients Price Forecast by Application (2023-2028) & (US$/Ton)
    Table 47. North America Specialty Biopharmaceutical Excipients Sales by Type (2017-2022) & (Tons)
    Table 48. North America Specialty Biopharmaceutical Excipients Sales by Type (2023-2028) & (Tons)
    Table 49. North America Specialty Biopharmaceutical Excipients Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Specialty Biopharmaceutical Excipients Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Specialty Biopharmaceutical Excipients Sales by Application (2017-2022) & (Tons)
    Table 52. North America Specialty Biopharmaceutical Excipients Sales by Application (2023-2028) & (Tons)
    Table 53. North America Specialty Biopharmaceutical Excipients Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Specialty Biopharmaceutical Excipients Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Specialty Biopharmaceutical Excipients Sales by Country (2017-2022) & (Tons)
    Table 56. North America Specialty Biopharmaceutical Excipients Sales by Country (2023-2028) & (Tons)
    Table 57. North America Specialty Biopharmaceutical Excipients Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Specialty Biopharmaceutical Excipients Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Specialty Biopharmaceutical Excipients Sales by Type (2017-2022) & (Tons)
    Table 60. Europe Specialty Biopharmaceutical Excipients Sales by Type (2023-2028) & (Tons)
    Table 61. Europe Specialty Biopharmaceutical Excipients Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Specialty Biopharmaceutical Excipients Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Specialty Biopharmaceutical Excipients Sales by Application (2017-2022) & (Tons)
    Table 64. Europe Specialty Biopharmaceutical Excipients Sales by Application (2023-2028) & (Tons)
    Table 65. Europe Specialty Biopharmaceutical Excipients Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Specialty Biopharmaceutical Excipients Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Specialty Biopharmaceutical Excipients Sales by Country (2017-2022) & (Tons)
    Table 68. Europe Specialty Biopharmaceutical Excipients Sales by Country (2023-2028) & (Tons)
    Table 69. Europe Specialty Biopharmaceutical Excipients Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Specialty Biopharmaceutical Excipients Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Specialty Biopharmaceutical Excipients Sales by Type (2017-2022) & (Tons)
    Table 72. Asia Pacific Specialty Biopharmaceutical Excipients Sales by Type (2023-2028) & (Tons)
    Table 73. Asia Pacific Specialty Biopharmaceutical Excipients Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Specialty Biopharmaceutical Excipients Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Specialty Biopharmaceutical Excipients Sales by Application (2017-2022) & (Tons)
    Table 76. Asia Pacific Specialty Biopharmaceutical Excipients Sales by Application (2023-2028) & (Tons)
    Table 77. Asia Pacific Specialty Biopharmaceutical Excipients Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Specialty Biopharmaceutical Excipients Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Specialty Biopharmaceutical Excipients Sales by Region (2017-2022) & (Tons)
    Table 80. Asia Pacific Specialty Biopharmaceutical Excipients Sales by Region (2023-2028) & (Tons)
    Table 81. Asia Pacific Specialty Biopharmaceutical Excipients Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Specialty Biopharmaceutical Excipients Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Specialty Biopharmaceutical Excipients Sales by Type (2017-2022) & (Tons)
    Table 84. Latin America Specialty Biopharmaceutical Excipients Sales by Type (2023-2028) & (Tons)
    Table 85. Latin America Specialty Biopharmaceutical Excipients Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Specialty Biopharmaceutical Excipients Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Specialty Biopharmaceutical Excipients Sales by Application (2017-2022) & (Tons)
    Table 88. Latin America Specialty Biopharmaceutical Excipients Sales by Application (2023-2028) & (Tons)
    Table 89. Latin America Specialty Biopharmaceutical Excipients Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Specialty Biopharmaceutical Excipients Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Specialty Biopharmaceutical Excipients Sales by Country (2017-2022) & (Tons)
    Table 92. Latin America Specialty Biopharmaceutical Excipients Sales by Country (2023-2028) & (Tons)
    Table 93. Latin America Specialty Biopharmaceutical Excipients Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Specialty Biopharmaceutical Excipients Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Specialty Biopharmaceutical Excipients Sales by Type (2017-2022) & (Tons)
    Table 96. Middle East and Africa Specialty Biopharmaceutical Excipients Sales by Type (2023-2028) & (Tons)
    Table 97. Middle East and Africa Specialty Biopharmaceutical Excipients Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Specialty Biopharmaceutical Excipients Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Specialty Biopharmaceutical Excipients Sales by Application (2017-2022) & (Tons)
    Table 100. Middle East and Africa Specialty Biopharmaceutical Excipients Sales by Application (2023-2028) & (Tons)
    Table 101. Middle East and Africa Specialty Biopharmaceutical Excipients Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Specialty Biopharmaceutical Excipients Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Specialty Biopharmaceutical Excipients Sales by Country (2017-2022) & (Tons)
    Table 104. Middle East and Africa Specialty Biopharmaceutical Excipients Sales by Country (2023-2028) & (Tons)
    Table 105. Middle East and Africa Specialty Biopharmaceutical Excipients Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Specialty Biopharmaceutical Excipients Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Merck KGaA Corporation Information
    Table 108. Merck KGaA Description and Major Businesses
    Table 109. Merck KGaA Specialty Biopharmaceutical Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 110. Merck KGaA Specialty Biopharmaceutical Excipients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Merck KGaA Recent Developments
    Table 112. Signet Excipients Pvt. Ltd Corporation Information
    Table 113. Signet Excipients Pvt. Ltd Description and Major Businesses
    Table 114. Signet Excipients Pvt. Ltd Specialty Biopharmaceutical Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 115. Signet Excipients Pvt. Ltd Specialty Biopharmaceutical Excipients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Signet Excipients Pvt. Ltd Recent Developments
    Table 117. Sigachi Industries Limited Corporation Information
    Table 118. Sigachi Industries Limited Description and Major Businesses
    Table 119. Sigachi Industries Limited Specialty Biopharmaceutical Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 120. Sigachi Industries Limited Specialty Biopharmaceutical Excipients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Sigachi Industries Limited Recent Developments
    Table 122. Associated British Foods plc Corporation Information
    Table 123. Associated British Foods plc Description and Major Businesses
    Table 124. Associated British Foods plc Specialty Biopharmaceutical Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 125. Associated British Foods plc Specialty Biopharmaceutical Excipients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Associated British Foods plc Recent Developments
    Table 127. Spectrum Chemical Manufacturing Corp. Corporation Information
    Table 128. Spectrum Chemical Manufacturing Corp. Description and Major Businesses
    Table 129. Spectrum Chemical Manufacturing Corp. Specialty Biopharmaceutical Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 130. Spectrum Chemical Manufacturing Corp. Specialty Biopharmaceutical Excipients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Spectrum Chemical Manufacturing Corp. Recent Developments
    Table 132. Roquette Freres Corporation Information
    Table 133. Roquette Freres Description and Major Businesses
    Table 134. Roquette Freres Specialty Biopharmaceutical Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 135. Roquette Freres Specialty Biopharmaceutical Excipients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Roquette Freres Recent Developments
    Table 137. IMCD Corporation Information
    Table 138. IMCD Description and Major Businesses
    Table 139. IMCD Specialty Biopharmaceutical Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 140. IMCD Specialty Biopharmaceutical Excipients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. IMCD Recent Developments
    Table 142. Clariant Corporation Information
    Table 143. Clariant Description and Major Businesses
    Table 144. Clariant Specialty Biopharmaceutical Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 145. Clariant Specialty Biopharmaceutical Excipients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Clariant Recent Developments
    Table 147. DFE Pharma Corporation Information
    Table 148. DFE Pharma Description and Major Businesses
    Table 149. DFE Pharma Specialty Biopharmaceutical Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 150. DFE Pharma Specialty Biopharmaceutical Excipients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. DFE Pharma Recent Developments
    Table 152. Colorcon Corporation Information
    Table 153. Colorcon Description and Major Businesses
    Table 154. Colorcon Specialty Biopharmaceutical Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 155. Colorcon Specialty Biopharmaceutical Excipients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Colorcon Recent Developments
    Table 157. BASF Corporation Information
    Table 158. BASF Description and Major Businesses
    Table 159. BASF Specialty Biopharmaceutical Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 160. BASF Specialty Biopharmaceutical Excipients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. BASF Recent Developments
    Table 162. Evonik Industries Corporation Information
    Table 163. Evonik Industries Description and Major Businesses
    Table 164. Evonik Industries Specialty Biopharmaceutical Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 165. Evonik Industries Specialty Biopharmaceutical Excipients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 166. Evonik Industries Recent Developments
    Table 167. J. RETTENMAIER & SOHNE GmbH Corporation Information
    Table 168. J. RETTENMAIER & SOHNE GmbH Description and Major Businesses
    Table 169. J. RETTENMAIER & SOHNE GmbH Specialty Biopharmaceutical Excipients Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2017-2022)
    Table 170. J. RETTENMAIER & SOHNE GmbH Specialty Biopharmaceutical Excipients Product Model Numbers, Pictures, Descriptions and Specifications
    Table 171. J. RETTENMAIER & SOHNE GmbH Recent Developments
    Table 172. Key Raw Materials Lists
    Table 173. Raw Materials Key Suppliers Lists
    Table 174. Specialty Biopharmaceutical Excipients Distributors List
    Table 175. Specialty Biopharmaceutical Excipients Customers List
    Table 176. Specialty Biopharmaceutical Excipients Market Trends
    Table 177. Specialty Biopharmaceutical Excipients Market Drivers
    Table 178. Specialty Biopharmaceutical Excipients Market Challenges
    Table 179. Specialty Biopharmaceutical Excipients Market Restraints
    Table 180. Research Programs/Design for This Report
    Table 181. Key Data Information from Secondary Sources
    Table 182. Key Data Information from Primary Sources
List of Figures
    Figure 1. Specialty Biopharmaceutical Excipients Product Picture
    Figure 3. Global Specialty Biopharmaceutical Excipients Market Share by Type in 2021 & 2028
    Figure 3. 膨胀剂 Product Picture
    Figure 4. 溶解度增强剂 Product Picture
    Figure 5. 表面活性剂 Product Picture
    Figure 6. 其他 Product Picture
    Figure 7. Global Specialty Biopharmaceutical Excipients Market Share by Application in 2021 & 2028
    Figure 8. Oral Medication
    Figure 9. Injection Medicine
    Figure 10. Other
    Figure 11. Specialty Biopharmaceutical Excipients Report Years Considered
    Figure 12. Global Specialty Biopharmaceutical Excipients Sales 2017-2028 (Tons)
    Figure 13. Global Specialty Biopharmaceutical Excipients Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Specialty Biopharmaceutical Excipients Revenue 2017-2028 (US$ Million)
    Figure 15. Global Specialty Biopharmaceutical Excipients Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Specialty Biopharmaceutical Excipients Sales Market Share by Region (2017-2022)
    Figure 17. Global Specialty Biopharmaceutical Excipients Sales Market Share by Region (2023-2028)
    Figure 18. North America Specialty Biopharmaceutical Excipients Sales YoY (2017-2028) & (Tons)
    Figure 19. North America Specialty Biopharmaceutical Excipients Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Specialty Biopharmaceutical Excipients Sales YoY (2017-2028) & (Tons)
    Figure 21. Europe Specialty Biopharmaceutical Excipients Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Specialty Biopharmaceutical Excipients Sales YoY (2017-2028) & (Tons)
    Figure 23. Asia-Pacific Specialty Biopharmaceutical Excipients Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Specialty Biopharmaceutical Excipients Sales YoY (2017-2028) & (Tons)
    Figure 25. Latin America Specialty Biopharmaceutical Excipients Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Specialty Biopharmaceutical Excipients Sales YoY (2017-2028) & (Tons)
    Figure 27. Middle East & Africa Specialty Biopharmaceutical Excipients Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Specialty Biopharmaceutical Excipients Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Specialty Biopharmaceutical Excipients in the World: Market Share by Specialty Biopharmaceutical Excipients Revenue in 2021
    Figure 30. Global Specialty Biopharmaceutical Excipients Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Specialty Biopharmaceutical Excipients Sales Market Share by Type (2017-2028)
    Figure 32. Global Specialty Biopharmaceutical Excipients Revenue Market Share by Type (2017-2028)
    Figure 33. Global Specialty Biopharmaceutical Excipients Sales Market Share by Application (2017-2028)
    Figure 34. Global Specialty Biopharmaceutical Excipients Revenue Market Share by Application (2017-2028)
    Figure 35. North America Specialty Biopharmaceutical Excipients Sales Market Share by Type (2017-2028)
    Figure 36. North America Specialty Biopharmaceutical Excipients Revenue Market Share by Type (2017-2028)
    Figure 37. North America Specialty Biopharmaceutical Excipients Sales Market Share by Application (2017-2028)
    Figure 38. North America Specialty Biopharmaceutical Excipients Revenue Market Share by Application (2017-2028)
    Figure 39. North America Specialty Biopharmaceutical Excipients Sales Share by Country (2017-2028)
    Figure 40. North America Specialty Biopharmaceutical Excipients Revenue Share by Country (2017-2028)
    Figure 41. U.S. Specialty Biopharmaceutical Excipients Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Specialty Biopharmaceutical Excipients Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Specialty Biopharmaceutical Excipients Sales Market Share by Type (2017-2028)
    Figure 44. Europe Specialty Biopharmaceutical Excipients Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Specialty Biopharmaceutical Excipients Sales Market Share by Application (2017-2028)
    Figure 46. Europe Specialty Biopharmaceutical Excipients Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Specialty Biopharmaceutical Excipients Sales Share by Country (2017-2028)
    Figure 48. Europe Specialty Biopharmaceutical Excipients Revenue Share by Country (2017-2028)
    Figure 49. Germany Specialty Biopharmaceutical Excipients Revenue (2017-2028) & (US$ Million)
    Figure 50. France Specialty Biopharmaceutical Excipients Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Specialty Biopharmaceutical Excipients Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Specialty Biopharmaceutical Excipients Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Specialty Biopharmaceutical Excipients Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Specialty Biopharmaceutical Excipients Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Specialty Biopharmaceutical Excipients Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Specialty Biopharmaceutical Excipients Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Specialty Biopharmaceutical Excipients Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Specialty Biopharmaceutical Excipients Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Specialty Biopharmaceutical Excipients Revenue Share by Region (2017-2028)
    Figure 60. China Specialty Biopharmaceutical Excipients Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Specialty Biopharmaceutical Excipients Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Specialty Biopharmaceutical Excipients Revenue (2017-2028) & (US$ Million)
    Figure 63. India Specialty Biopharmaceutical Excipients Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Specialty Biopharmaceutical Excipients Revenue (2017-2028) & (US$ Million)
    Figure 65. Taiwan Specialty Biopharmaceutical Excipients Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Specialty Biopharmaceutical Excipients Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Specialty Biopharmaceutical Excipients Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Specialty Biopharmaceutical Excipients Revenue (2017-2028) & (US$ Million)
    Figure 69. Philippines Specialty Biopharmaceutical Excipients Revenue (2017-2028) & (US$ Million)
    Figure 70. Latin America Specialty Biopharmaceutical Excipients Sales Market Share by Type (2017-2028)
    Figure 71. Latin America Specialty Biopharmaceutical Excipients Revenue Market Share by Type (2017-2028)
    Figure 72. Latin America Specialty Biopharmaceutical Excipients Sales Market Share by Application (2017-2028)
    Figure 73. Latin America Specialty Biopharmaceutical Excipients Revenue Market Share by Application (2017-2028)
    Figure 74. Latin America Specialty Biopharmaceutical Excipients Sales Share by Country (2017-2028)
    Figure 75. Latin America Specialty Biopharmaceutical Excipients Revenue Share by Country (2017-2028)
    Figure 76. Mexico Specialty Biopharmaceutical Excipients Revenue (2017-2028) & (US$ Million)
    Figure 77. Brazil Specialty Biopharmaceutical Excipients Revenue (2017-2028) & (US$ Million)
    Figure 78. Argentina Specialty Biopharmaceutical Excipients Revenue (2017-2028) & (US$ Million)
    Figure 79. Middle East and Africa Specialty Biopharmaceutical Excipients Sales Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Specialty Biopharmaceutical Excipients Revenue Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Specialty Biopharmaceutical Excipients Sales Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Specialty Biopharmaceutical Excipients Revenue Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Specialty Biopharmaceutical Excipients Sales Share by Country (2017-2028)
    Figure 84. Middle East and Africa Specialty Biopharmaceutical Excipients Revenue Share by Country (2017-2028)
    Figure 85. Turkey Specialty Biopharmaceutical Excipients Revenue (2017-2028) & (US$ Million)
    Figure 86. Saudi Arabia Specialty Biopharmaceutical Excipients Revenue (2017-2028) & (US$ Million)
    Figure 87. U.A.E Specialty Biopharmaceutical Excipients Revenue (2017-2028) & (US$ Million)
    Figure 88. Specialty Biopharmaceutical Excipients Value Chain
    Figure 89. Specialty Biopharmaceutical Excipients Production Process
    Figure 90. Channels of Distribution
    Figure 91. Distributors Profiles
    Figure 92. Bottom-up and Top-down Approaches for This Report
    Figure 93. Data Triangulation
    Figure 94. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck KGaA
Signet Excipients Pvt. Ltd
Sigachi Industries Limited
Associated British Foods plc
Spectrum Chemical Manufacturing Corp.
Roquette Freres
IMCD
Clariant
DFE Pharma
Colorcon
BASF
Evonik Industries
J. RETTENMAIER & SOHNE GmbH
Frequently Asked Questions
Specialty Biopharmaceutical Excipients report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Specialty Biopharmaceutical Excipients report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Specialty Biopharmaceutical Excipients report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Hybrid Wiper System

Hybrid Wiper System market is segmented by Type and by Application. Players, stakeholders, and ot ... Read More